Background Digital breast tomosynthesis (DBT) is considered superior to digital mammography (DM) for women with dense breasts. Purpose To identify differences in screening outcomes, including rates of recall, false-positive (FP) findings, biopsy, cancer detection rate, positive predictive value of recalls and biopsies, and histopathologic tumor characteristics by density using DBT combined with two-dimensional synthetic mammography (SM) (hereafter, DBT+SM) versus DM. Materials and Methods This randomized controlled trial comparing DBT+SM and DM was performed in Bergen as part of BreastScreen Norway, 2016-2017. Automated software measured density (Volpara Density Grade [VDG], 1-4). The outcomes were compared for DBT+SM versus DM by VDG in descriptive analyses. A stratified log-binomial regression model was used to estimate relative risk of outcomes in subgroups by screening technique. Results Data included 28 749 women, 14 380 of whom were screened with DBT+SM and 14 369 of whom were screened with DM (both groups: median age, 59 years; interquartile range [IQR], 54-64 years). The recall rate was lower for women screened with DBT+SM versus those screened with DM for VDG 1 (2.1% [81 of 3929] vs 3.3% [106 of 3212]; = .001) and VDG 2 (3.2% [200 of 6216] vs 4.3% [267 of 6280]; = .002). For DBT+SM, adjusted relative risk of recall (VDG 2: 1.8; < .001; VDG 3: 2.4; < .001; VDG 4: 1.8; = .02) and screen-detected breast cancer (VDG 2: 2.4; = .004; VDG 3: 2.8; = .01; VDG 4: 2.8; = .05) increased with VDG, whereas no differences were observed for DM (relative risk of recall for VDG 2: 1.3; = .06; VDG 3: 1.1; = .41; VDG 4: 1.1; = .71; and relative risk of screen-detected breast cancer for VDG 2: 1.7; = .13; VDG 3: 2.1; = .06; VDG 4: 2.2; = .15). Conclusion Screening with digital breast tomosynthesis combined with synthetic two-dimensional mammograms (DBT+SM) versus digital mammography (DM) yielded lower recall rates for women with Volpara Density Grade (VDG) 1 and VDG 2. Adjusted relative risk of recall and screen-detected breast cancer increased with denser breasts for DBT+SM but not for DM. © RSNA, 2020 See also the editorial by Sechopoulos and Athanasiou in this issue.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1148/radiol.2020201150 | DOI Listing |
Clin Rehabil
January 2025
Rehabilitation, Campus Docent Sant Joan De Deu. Universitat de Barcelona, Barcelona, Spain.
Objective: To evaluate the effect of integrating a specific balance-training program focused on static balance to the conventional rehabilitation program on dynamic balance, risk of falls, and activities of daily living (ADLs) in older adults post-stroke.
Design: A single-blinded randomized controlled trial.
Setting: Institutional Intermediate Care Hospital.
Gynecol Obstet Fertil Senol
January 2025
Department of Obstetrics and Gynaecology, Hôpital Saint Joseph, Marseille, France; Image2 center, Marseille, France. Electronic address:
The management of a fetus suspected of having a variation in genital development is a complex situation. In cases of complete discordance or an unusual appearance of the external genitalia (EG), management always begins with a diagnostic morphological ultrasound. This ultrasound aims to provide detailed imaging of the EG and internal genitalia (IG), focusing on identifying the presence of Müllerian derivatives and detecting any associated malformations.
View Article and Find Full Text PDFInt J Dev Neurosci
February 2025
Department of Molecular Biology and Genetics, Faculty of Engineering and Natural Sciences, Uskudar University, Istanbul, Turkey.
Alzheimers Dement (Amst)
November 2024
Alzheimer Center Amsterdam, Neurology Vrije Universiteit Amsterdam Amsterdam UMC Amsterdam The Netherlands.
Background: Recent advancements in Alzheimer's disease (AD) biomarker research and clinical trials prompt reflection on the value and consequently appropriate use of tau positron emission tomography (tau-PET) in the future.
Methods: We conducted an online survey among dementia and PET experts worldwide to investigate the anticipated future role of tau-PET in clinical practice and trials.
Results: Two hundred sixty-eight dementia experts, comprising 143 clinicians and 121 researchers, covering six continents participated.
J Obstet Gynaecol Res
January 2025
Department of reproductive medicine, Shenzhen Longgang Central Hospital, Shenzhen, China.
Background: Recurrent miscarriage (RM) is influenced by immune factors, particularly regulatory T cells, which can impact immune function and miscarriage risk. Vitamin D (VD) is known to regulate the immune system, potentially improving pregnancy outcomes in RM patients. This study aims to assess the effect of VD adjuvant therapy on regulatory T cells and pregnancy outcomes in RM patients.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!